This approach offers hope for a revolution in the treatment of colorectal cancer. A groundbreaking immunotherapy drug has shown promising results in the treatment of colorectal...
Approximately 60 million women in the United States are affected by CVD, but only about 44% of them recognize CVD as a serious health threat.1 This...
This article was featured in the One Story to Read Today newsletter. Sign up for it here. The latest weight-loss drugs are rightly hailed as game...
Christopher Haqq, MD, PhD About the Phase 2 AMPLIFY-7p Study Trial Name: First in Human Phase 1/2 Trial of ELI-002 7P Immunotherapy as Treatment for Subjects...
Scott Gray, cofounder and CEO, Clincierge | Image Credit: Clincierge October is Breast Cancer Awareness Month, yet the significant impact of this disease is felt worldwide...
No follow-up for many with positive findings In a recent study, published in the Annals of American Thoracic Society, Triplette and colleagues from the University of...
Recent Comments